118 related articles for article (PubMed ID: 38702281)
21. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.
Lubezky N; Metser U; Geva R; Nakache R; Shmueli E; Klausner JM; Even-Sapir E; Figer A; Ben-Haim M
J Gastrointest Surg; 2007 Apr; 11(4):472-8. PubMed ID: 17436132
[TBL] [Abstract][Full Text] [Related]
22. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?
de Haas RJ; Wicherts DA; Flores E; Azoulay D; Castaing D; Adam R
Ann Surg; 2008 Oct; 248(4):626-37. PubMed ID: 18936576
[TBL] [Abstract][Full Text] [Related]
23. Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy.
Fan XX; Lv SY; Zhang MW; Dai XY; Zhao JP; Mao DF; Zhang Y
World J Surg Oncol; 2020 Apr; 18(1):76. PubMed ID: 32312256
[TBL] [Abstract][Full Text] [Related]
24. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.
Yamada H; Kondo S; Okushiba S; Morikawa T; Katoh H
World J Surg; 2001 Sep; 25(9):1129-33. PubMed ID: 11571947
[TBL] [Abstract][Full Text] [Related]
25. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
[TBL] [Abstract][Full Text] [Related]
26. Survival after repeat hepatectomy for recurrent colorectal liver metastasis: A review and meta-analysis of prognostic factors.
Wang SJ; Si XY; Cai ZB; Zhou YM
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):313-320. PubMed ID: 30826293
[TBL] [Abstract][Full Text] [Related]
27. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
[TBL] [Abstract][Full Text] [Related]
28. Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.
Cheung HMC; Karanicolas PJ; Hsieh E; Coburn N; Maraj T; Kim JK; Elhakim H; Haider MA; Law C; Milot L
Eur Radiol; 2018 Aug; 28(8):3505-3512. PubMed ID: 29476216
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
[TBL] [Abstract][Full Text] [Related]
30. Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
Serrano PE; Gu CS; Moulton CA; Husien M; Jalink D; Martel G; Tsang ME; Hallet J; McAlister V; Gallinger S; Levine M
J Surg Oncol; 2020 May; 121(6):1001-1006. PubMed ID: 32034769
[TBL] [Abstract][Full Text] [Related]
31. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.
Reddy SK; Zorzi D; Lum YW; Barbas AS; Pawlik TM; Ribero D; Abdalla EK; Choti MA; Kemp C; Vauthey JN; Morse MA; White RR; Clary BM
Ann Surg Oncol; 2009 Jul; 16(7):1809-19. PubMed ID: 18979139
[TBL] [Abstract][Full Text] [Related]
32. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
[TBL] [Abstract][Full Text] [Related]
33. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.
Kornprat P; Jarnagin WR; Gonen M; DeMatteo RP; Fong Y; Blumgart LH; D'Angelica M
Ann Surg Oncol; 2007 Mar; 14(3):1151-60. PubMed ID: 17195913
[TBL] [Abstract][Full Text] [Related]
34. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of patients with 10 or more colorectal liver metastases.
Allard MA; Adam R; Giuliante F; Lapointe R; Hubert C; Ijzermans JNM; Mirza DF; Elias D; Laurent C; Gruenberger T; Poston G; Letoublon C; Isoniemi H; Lucidi V; Popescu I; Figueras J
Br J Cancer; 2017 Aug; 117(5):604-611. PubMed ID: 28728167
[TBL] [Abstract][Full Text] [Related]
36. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.
Neofytou K; Giakoustidis A; Neves MC; Morrison D; Giakoustidis D; Khan AZ; Stebbing J; Mudan S
Langenbecks Arch Surg; 2017 Jun; 402(4):599-605. PubMed ID: 27043945
[TBL] [Abstract][Full Text] [Related]
37. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.
Andreou A; Aloia TA; Brouquet A; Dickson PV; Zimmitti G; Maru DM; Kopetz S; Loyer EM; Curley SA; Abdalla EK; Vauthey JN
Ann Surg; 2013 Jun; 257(6):1079-88. PubMed ID: 23426338
[TBL] [Abstract][Full Text] [Related]
38. Recurrence location after resection of colorectal liver metastases influences prognosis.
Govaert KM; van Kessel CS; Steller EJ; Emmink BL; Molenaar IQ; Kranenburg O; van Hillegersberg R; Borel Rinkes IH
J Gastrointest Surg; 2014 May; 18(5):952-60. PubMed ID: 24474631
[TBL] [Abstract][Full Text] [Related]
39. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
Yopp AC; Shia J; Butte JM; Allen PJ; Fong Y; Jarnagin WR; DeMatteo RP; D'Angelica MI
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S339-46. PubMed ID: 21584832
[TBL] [Abstract][Full Text] [Related]
40. Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits?
Wong LH; Sutton TL; Walker BS; Lopez CD; Kardosh A; Eil RL; Chen EY; Billingsley KG; Mayo SC
Am J Surg; 2021 Jun; 221(6):1114-1118. PubMed ID: 33722380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
